Tobramycin (Peak)
The highest tobramycin level in your blood after a dose, used to check this IV antibiotic is reaching an effective level.
AI-verified against cited sources. Awaiting expert reviewLOINC 4057-6
Check your result
Type your result to see where it falls.
Nothing you type here leaves your browser.
What it is
Tobramycin is an antibiotic given by IV or injection for serious infections caused by certain bacteria, such as Pseudomonas. A peak level is drawn shortly after a dose finishes, when the amount in the blood is highest. Your care team reads it together with a trough level and your kidney function. Inhaled tobramycin, used in cystic fibrosis, usually gives much lower blood levels than IV tobramycin.
Why it matters
Tobramycin works better when the peak is high enough, but it can harm the kidneys and the inner ear (hearing and balance) when levels stay high for a long time. FDA labeling says prolonged concentrations above 12 mcg/mL should be avoided. Kidney function changes the level a lot, so the peak helps your team keep the dose in a useful and safe range.
If it’s low
A peak below the usual range can mean the dose was smaller than your body needs, or that the sample was drawn later than planned. Your team may repeat the level or adjust the dose. A low peak does not by itself mean the infection is not responding.
Common causes
- A sample drawn too long after the infusion ended
- Faster clearance by the kidneys, or a larger volume of body fluid, which happens in some people, including some with cystic fibrosis
- A dose that is small for the person's size
- A slow or incomplete infusion, for example from a line problem
What can help
- Ask your team whether the timing of the draw was right
- Ask whether the level should be repeated before the dose is changed
If it’s high
A peak above the usual range means a high amount right after the dose. Some planned regimens, called once-daily or extended-interval dosing, aim for much higher peaks than older several-times-a-day schedules, so your team's target may be different from the one printed on your report. Levels that stay high for a long time are linked to a greater chance of hearing and kidney harm.
Common causes
- A once-daily (extended-interval) schedule, which produces higher peaks by design
- A sample drawn too soon after the infusion ended, before the drug has spread through the body
- A sample drawn from the IV line that the drug ran through
- Reduced kidney function or dehydration, which slow clearance
- A dose that is large for the person's size
What can help
- Ask your care team which dosing schedule you are on, because target peaks differ between schedules
- Make sure your blood draw was timed as instructed and not taken from the infusion line
- Talk with your care team about drinking enough fluid and about tracking your kidney function
Usual ranges
What labs print as the reference range, by who was tested. Ranges differ a little between labs, so the range on your own report is the one your result is judged against.
For adults: 5–10 µg/mL. Source: Quest Diagnostics, DailyMed, National Library of Medicine.
- Adults (this one applies)5–10 µg/mL
Sources: Quest Diagnostics, DailyMed, National Library of Medicine
What can affect your result
- Time between the end of the infusion and the blood draw
- Dosing schedule: conventional (several times a day) or extended-interval (once a day)
- Kidney function and hydration
- Body size, fluid status, and conditions such as cystic fibrosis
- Whether the sample came from the infusion line
- A sample drawn at the wrong time after the dose changes the result a lot. The lab and your care team need the exact time the infusion ended.
- Drawing blood from the same IV line used for the infusion can falsely raise the result.
- Quest rejects serum separator (gel) tubes for this test; it asks for a red-top tube without gel (plasma in EDTA or heparin tubes is also accepted).
About 30 minutes after the end of an IV infusion, or 60–90 minutes after an intramuscular injection (Quest). Timing matters more than time of day. Tobramycin has a serum half-life of about 2 hours with normal kidney function, so a peak reflects the most recent dose. Kidney problems make it last longer (FDA labeling).
When to talk to a clinician
Tell your care team promptly about hearing loss, ringing in the ears, dizziness or balance trouble, much less urine, or new swelling while you are on tobramycin. Call 911 or your local emergency number for trouble breathing, swelling of the face or throat, or fainting.
Questions you could ask
- How often will my levels and kidney tests be checked while I am on this antibiotic?
- Which signs of hearing or kidney problems should I report right away?
- Am I on a once-daily or several-times-a-day schedule, and what peak is my team aiming for?
- Was this sample drawn at the right time, and not from the infusion line?
- Should we check my kidney function and my hearing?
- Could the timing of the draw explain this low result?
Questions people ask
Why is the timing of a peak sample so strict?
The level falls quickly after the infusion ends, so a sample drawn a little early or late can look very different. Quest asks for the peak 30 minutes after the end of an IV infusion, or 60–90 minutes after a muscle injection. Make sure the infusion end time and the draw time are written down.
Why is my target peak different from the range on my report?
The printed range fits conventional dosing, where the drug is given several times a day. Once-daily (extended-interval) dosing is meant to give a higher peak and a very low trough, so your care team uses a different target. Ask which schedule you are on.
Show the science and sources
Units
- 1 µg/mL = 1 µg/mL
- 1 µg/mL = 1 mg/L
- 1 µg/mL = 2.139 µmol/L
Open the Tobramycin peak unit converter
For clinicians and researchers
Tobramycin is an aminoglycoside with concentration-dependent bacterial killing, eliminated almost entirely by glomerular filtration (serum half-life about 2 hours with normal renal function, longer in renal impairment and neonates). FDA labeling states that nephrotoxicity is more likely if troughs fail to fall below 2 mcg/mL and is most closely related to the AUC, that prolonged concentrations above 12 mcg/mL should be avoided, and that therapeutic serum levels are generally considered to range from 4 to 6 mcg/mL. Quest reports a 5.0–10.0 mg/L peak interval by immunoassay for conventional dosing. Extended-interval (once-daily) regimens deliberately produce much higher peaks and aim for a low trough, so peak targets and interpretation differ and are usually handled by a dosing protocol or a pharmacist. Peak, trough and random results are interpreted with the dose, infusion end time and sample time. mg/L and µg/mL are the same unit.
LOINC 4057-6 (primary), 22751-2. Specimen: serum-or-plasma.
Sources
- Tobramycin, Peak (test code 8576), Quest Diagnostics
- Tobramycin injection prescribing information, DailyMed, National Library of Medicine
- Tobramycin (PubChem compound 36294), PubChem, National Library of Medicine
AI-verified against cited sources. Awaiting expert review. Last reviewed 2026-10-03. How we build and check these pages.